SLC5A6 Mutations in Axonal Sensorimotor Polyneuropathy Patients Concurrent With Sodium Dependent Multivitamin Transporter Deficiency and Improved Effects by Multivitamin Therapy
Journal of the Peripheral Nervous System · 2025
DOI: 10.1111/jns.70030 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of the Peripheral Nervous System, 2025. Verfasst von Byung Kwon Pi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Kongju National University, Gongju, Korea. Hauptthemen laut MEDLINE: Polyneuropathies, Vitamins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Korea Health Industry Development Institute, Ministry of Science and ICT, Ministry of Health and Welfare.
Abstract (Originalsprache)
Background and Aims The SLC5A6 gene encodes a transmembrane protein responsible for transporting biotin, pantothenic acid, and lipoic acid. Mutations in SLC5A6 have shown a wide spectrum of clinical phenotypes, such as sodium‐dependent multivitamin transporter deficiency (SMVTD), childhood‐onset biotin‐responsive peripheral motor neuropathy (COMNB), and mixed axonal and demyelinating sensory motor neuropathy. The purpose of this study was to identify pathogenic SLC5A6 mutations in the Korean CMT cohort.
Methods
This study performed whole exome sequencing to identify the genetic cause for two independent patients with early onset axonal sensorimotor polyneuropathy and SMVTD. We also examined the therapeutic effects of multivitamin replenishment on a patient with SLC5A6 mutations.
Results
We identified compound heterozygous variants of SLC5A6 in two patients (p.Arg94X and p.Phe522Ser in patient 1; p.Cys443Tyr and p.Phe513_Lys515delinsLeu in patient 2). In patient 2, an oral regimen comprising biotin, lipoic acid, and pantothenic acid demonstrated significant therapeutic effects, including cessation of cyclic vomiting, resolution of skin lesions on the fingers, and improvements in muscle weakness affecting both the upper and lower extremities.
Interpretation
This study represents the first report of novel heterozygous SLC5A6 mutations in patients with axonal CMT and SMVTD, expanding the phenotypic spectrum associated with SLC5A6 mutations. Notably, we observed significant therapeutic effects from multivitamin treatment in a patient.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Kongju National University, Gongju, Korea.
- Cell & Gene Therapy Institute, Samsung Medical Center, Seoul, Korea.
- Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
ORCID-Profile: Ki Wha Chung
Förderung
- Korea Health Industry Development Institute
- Ministry of Science and ICT
- Ministry of Health and Welfare
- Samsung Medical Center
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
- Samsung Medical Center, Sungkyunkwan University
Zitieren
APA
Pi, B. K., Lee, A. J., Nam, S. H., Chung, K. W., & Choi, B. O. (2025). SLC5A6 Mutations in Axonal Sensorimotor Polyneuropathy Patients Concurrent With Sodium Dependent Multivitamin Transporter Deficiency and Improved Effects by Multivitamin Therapy. Journal of the Peripheral Nervous System. https://doi.org/10.1111/jns.70030
Vancouver
Pi BK, Lee AJ, Nam SH, Chung KW, Choi BO. SLC5A6 Mutations in Axonal Sensorimotor Polyneuropathy Patients Concurrent With Sodium Dependent Multivitamin Transporter Deficiency and Improved Effects by Multivitamin Therapy. Journal of the Peripheral Nervous System. 2025. doi:10.1111/jns.70030
BibTeX
@article{Pi2025,
author = {Pi, Byung Kwon and Lee, Ah Jin and Nam, Soo Hyun and Chung, Ki Wha and Choi, Byung-Ok},
title = {SLC5A6 Mutations in Axonal Sensorimotor Polyneuropathy Patients Concurrent With Sodium Dependent Multivitamin Transporter Deficiency and Improved Effects by Multivitamin Therapy},
journal = {Journal of the Peripheral Nervous System},
year = {2025},
doi = {10.1111/jns.70030}
}
EUVIMED